Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Preparation method of tryptanthrin compound and new application of tryptanthrin compound in preparing indoleamine-2,3-dioxygenase (IDO) inhibitor

A compound and inhibitor technology, applied in antiviral agents, drug combinations, medical preparations containing active ingredients, etc., can solve the problems of low extraction rate, long separation process, difficult to meet research and clinical drug use, etc., to achieve good research with the development of the effect

Active Publication Date: 2014-05-14
SHENYANG XINMA PHARMA
View PDF1 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although tryptanthrin can be extracted from indigo plants such as Polygonum indigo, Isatis indigo, and other indigo plants and metabolites of microorganisms, the separation process is long and the extraction rate is low, which is difficult to meet the needs of research and clinical medicine.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of tryptanthrin compound and new application of tryptanthrin compound in preparing indoleamine-2,3-dioxygenase (IDO) inhibitor
  • Preparation method of tryptanthrin compound and new application of tryptanthrin compound in preparing indoleamine-2,3-dioxygenase (IDO) inhibitor
  • Preparation method of tryptanthrin compound and new application of tryptanthrin compound in preparing indoleamine-2,3-dioxygenase (IDO) inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1: the preparation of tryptanthrin (formula I)

[0024]

[0025] Add 3mL toluene, 163mg (1mmol) isatoic anhydride (purchased from Shanghai Kangtuo Chemical Co., Ltd.), 147mg (1mmol) isatin (purchased from Aladdin Reagent Co., Ltd.), 505mg (5mmol) to a 25mL dry round bottom flask ) triethylamine, then heated up to 110°C, refluxed and stirred for 3-4h, after TLC detection showed that the reaction was complete, the solvent was evaporated under reduced pressure, and the residue was recrystallized from ethanol to obtain 228 mg of compound of formula I with a yield of 92%.

[0026] The characterization data are as follows: 1 H-NMR (400MHz, CDCl 3 )δ=8.64(d, 1H), 8.45(d, 1H), 8.04(d, 1H), 7.92(d, 1H), 7.88(t, 1H), 7.80(t, 1H), 7.69(t, 1H ), 7.44(t, 1H).

Embodiment 2

[0027] Embodiment 2: the preparation of 8-methyl tryptanthrin (formula II)

[0028]

[0029] Add 3 mL of toluene, 163 mg (1 mmol) isatoic anhydride, 161 mg (1 mmol) 5-methyl isatin (purchased from Qingdao Hexing Fine Chemical Co., Ltd.), 505 mg (5 mmol) triethylamine into a 25 mL dry round bottom flask , and then heated up to 110° C., refluxed and stirred for 3-4 hours. TLC showed that after the reaction was complete, the solvent was evaporated under reduced pressure, and the residue was recrystallized from ethanol to obtain 235 mg of the compound of formula II with a yield of 90%.

[0030] The characterization data are as follows: 1 H-NMR (400MHz, CDCl 3 )δ=8.49(d, 1H), 8.43(d, 1H), 8.02(d, 1H), 7.84(t, 1H), 7.67(m, 2H), 7.59(d, 1H), 2.46(s, 3H ).

Embodiment 3

[0031] Embodiment 3: the preparation of 8-fluorotryptanthin (formula III)

[0032]

[0033] Add 3 mL of toluene, 163 mg (1 mmol) isatoic anhydride, 165 mg (1 mmol) 5-fluoroisatin (see step (2) of Example 5 for its preparation method, 505 mg (5 mmol) three Ethylamine, then warmed up to 110°C, refluxed and stirred for 3-4 hours, TLC showed that after the reaction was completed, the solvent was evaporated under reduced pressure, and the residue was recrystallized from ethanol to obtain 242 mg of compound of formula III, with a yield of 91%.

[0034] The characterization data are as follows: 1 H-NMR (400MHz, CDCl 3 )δ=8.64(m, 1H), 8.44(d, 1H), 8.03(d, 1H), 7.87(t, 1H), 7.70(t, 1H), 7.58(m, 1H), 7.49(m, 1H ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method of tryptanthrin compound and a new application of tryptanthrin compound in preparing indoleamine-2,3-dioxygenase (IDO) inhibitor, in particular to an application of tryptanthrin compound in preparing IDO inhibitor and in preparing medicine for preventing and / or treating diseases having pathological characteristics of tryptophan metabolic disturbance mediated by IDO. The structure of the tryptanthrin compound is shown in formula A in the description, wherein R1 and R2 are respectively and independently selected from hydrogen, nitryl, C1 to C5 alkyl, halogen or piperazinyl. The tryptanthrin compound can be used as an IDO inhibitor with high activity and is used for treating diseases having pathological characteristics of tryptophan metabolic disturbance mediated by IDO such as tumor, cancer, Alzheimer disease, autoimmune disease, cataract, mental block, tristimania, anxiety neurosis, acquired immure deficiency syndrome (AIDS) and other serious diseases, and as a medicinal resource which is very difficult to get, the tryptanthrin compound has good potential on researching and developing new medicine.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and in particular relates to a preparation method of tryptanthrin compounds and their new application in preparing IDO inhibitors. Background technique [0002] Indoleamine 2,3-dioxygenase (Indoleamine 2,3-dioxygenase, IDO) is an enzyme containing heme in cells, and it is the only one outside the liver that can catalyze the metabolism of tryptophan to make it along the path of kynurenine The rate-limiting enzyme of the acid pathway breaks down to a series of metabolites including quinolinic acid (MacKenzie, C. R. et. al. Current Drug Metabolism, 2007, 8: 237-244.). Since the 1990s, indoleamine 2,3-dioxygenase (IDO) and its kynurenine pathway (Kynurenine pathway, KP), which catalyzes tryptophan metabolism, have been The important role it plays in various disease processes is attracting increasing attention. [0003] IDO is related to many physiological and pathological processes. Studies on p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/519A61P35/00A61P25/28A61P37/02A61P27/12A61P25/00A61P25/24A61P25/22A61P31/18A61P35/02
Inventor 匡春香王勇王淑君陈斌关玉晶刘莹田宁
Owner SHENYANG XINMA PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com